These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7690874)

  • 1. Clinical significance of the antibody to the putative core protein of hepatitis C virus in patients with chronic liver disease.
    Manzini P; Calvo PL; Brunetto MR; Baldi M; Abate ML; Oliveri F; Negro F; Balzola F; Saracco G; Verme G
    Liver; 1993 Aug; 13(4):222-6. PubMed ID: 7690874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
    Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
    Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
    Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
    Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
    Magrin S; Craxì A; Fabiano C; Fiorentino G; Marino L; Almasio P; Pinzello GB; Palazzo U; Vitale M; Maggio A
    J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of hepatitis C virus-associated chronic liver disease in India: comparison of HCV antibody assay with a polymerase chain reaction for the 5' noncoding region.
    Panigrahi AK; Nanda SK; Dixit RK; Acharya SK; Zuckerman AJ; Panda SK
    J Med Virol; 1994 Oct; 44(2):176-9. PubMed ID: 7531753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
    Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
    J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
    Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
    J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen.
    Katayama T; Mazda T; Kikuchi S; Harada S; Matsuura Y; Chiba J; Ohba H; Saito I; Miyamura T
    Hepatology; 1992 Mar; 15(3):391-4. PubMed ID: 1371981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up.
    Tanaka E; Kiyosawa K; Nakatsuji Y; Inoue Y; Miyamura T; Chiba J; Furuta S
    J Med Virol; 1993 Apr; 39(4):318-24. PubMed ID: 7684063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
    Nagayama R; Miyake K; Tsuda F; Okamoto H
    J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma.
    Watanabe Y; Harada S; Saito I; Miyamura T
    Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to hepatitis C virus and hepatitis C virus infection.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Fusamoto H; Kamada T
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():76-9. PubMed ID: 7689512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
    Bååth L; Widell A; Nordenfelt E
    J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study.
    Brillanti S; Garson JA; Tuke PW; Ring C; Briggs M; Masci C; Miglioli M; Barbara L; Tedder RS
    J Med Virol; 1991 Jun; 34(2):136-41. PubMed ID: 1716296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C as the cause of chronic non-A, non-B hepatitis: high sensitivity of simultaneous measurement of core and non-structural antibodies.
    Lin R; Yatuhashi H; Yano M; Farrell GC
    J Gastroenterol Hepatol; 1992; 7(5):459-62. PubMed ID: 1382656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR.
    Siemoneit K; da Silva Cardoso M; Wölpl A; Epple S; Wintersinger H; Koerner K; Kubanek B
    Ann Hematol; 1994 Sep; 69(3):129-33. PubMed ID: 8086507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short and long-term effects of interferon on serum markers of hepatitis C virus replication.
    Yatsuhashi H; Inoue O; Inokuchi K; Koga M; Nagataki S; Cha TA; Irvine B; Stempien M; Kolberg J; Urdea MS
    J Gastroenterol Hepatol; 1993; 8(1):1-6. PubMed ID: 8382537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.